Mizolastine
- Generic Name
- Mizolastine
- Drug Type
- Small Molecule
- Chemical Formula
- C24H25FN6O
- CAS Number
- 108612-45-9
- Unique Ingredient Identifier
- 244O1F90NA
Overview
Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).
Background
Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).
Indication
1.慢性特发性荨麻疹，急性荨麻疹，血管神经性水肿等过敏性皮肤疾患； 2.季节性过敏性鼻炎（花粉症）及常年性过敏性鼻炎； 3.过敏性结膜炎等。
Associated Conditions
- Perennial Allergic Rhinitis (PAR)
- Seasonal Allergic Rhinitis
- Urticaria
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath